Picard Medical, Inc.

$0.15-3.69%($-0.01)
TickerSpark Score
41/100
Weak
47
Valuation
45
Profitability
45
Growth
40
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PMI research report →

52-Week Range0% of range
Low $0.13
Current $0.15
High $13.68

Companywww.syncardia.com

Picard Medical, Inc. , through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure.

CEO
Patrick N. J. Schnegelsberg
IPO
2025
Employees
75
HQ
Tucson, AZ, US

Price Chart

-96.64% · this period
$13.20$6.68$0.15Aug 29Jan 09May 20

Valuation

Market Cap
$240.24M
P/E
-0.38
P/S
43.86
P/B
-7.92
EV/EBITDA
-12.69
Div Yield
0.00%

Profitability

Gross Margin
15.21%
Op Margin
-256.80%
Net Margin
-545.02%
ROE
499.20%
ROIC
-1249.11%

Growth & Income

Revenue
$4.94M · 12.50%
Net Income
$-27,000,000 · -28.24%
EPS
$-0.37 · -12.12%
Op Income
$-12,800,000
FCF YoY
-31.99%

Performance & Tape

52W High
$13.68
52W Low
$0.13
50D MA
$0.78
200D MA
$3.12
Beta
-1.54
Avg Volume
7.25M

Get TickerSpark's AI analysis on PMI

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Aug 11, 25Sindex SSI Lending, LLCother0
Aug 28, 25Skaggs Bernardother408,956
Aug 28, 25Schuster Mattother68,608
Aug 28, 25SCHNEGELSBERG PATRICK NJother2,378,124
Aug 28, 25Ye George Tianchengother0
Aug 28, 25Van Samother0
Aug 28, 25Skaggs Bernardother408,956
Aug 28, 25Schuster Mattother68,608
Aug 28, 25SCHNEGELSBERG PATRICK NJother2,378,124
Aug 28, 25Fang Richardother742,021

Our PMI Coverage

We haven't published any research on PMI yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate PMI Report →